Phosphorus derivatives as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9273077
SERIAL NO

13842951

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention features compounds of the general formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dalgarno, David C Brookline, US 55 602
Huang, Wei-Sheng Acton, US 58 567
Kohlmann, Anna Winchester, US 26 159
Li, Feng Winchester, US 810 5206
Liu, Shuangying Wellesley, US 9 134
Qi, Jiwei West Roxbury, US 29 416
Romero, Jan Antoinette C Somerville, US 22 330
Shakespeare, William C Southbourgh, US 74 1018
Thomas, R Mathew Sharon, US 22 396
Wang, Yihan Newton, US 122 1020
Zhu, Xiaotian Newton, US 73 1222
Zou, Dong Concord, US 30 436

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00